Univest
Univest
  • Markets

Laurus Labs Share Price Hits All-Time High of Rs 1,826 Today

  • August 3, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Laurus Labs Share Price Hits All-Time High of Rs 1,826 Today

Laurus Labs shares rise 0.42% to Rs 1,823.90 in today’s trade, hitting a fresh all-time high of Rs 1,826.00 during the session.

The Laurus Labs share price touched a fresh all-time high of Rs 1,826.00 in today’s trading session before settling at Rs 1,823.90, up 0.42% on the day. Laurus Labs extends a sustained uptrend that has seen the pharmaceutical and API manufacturer’s stock repeatedly break into new high territory in recent sessions.

A stock hitting an all-time high on a modest single-day gain, rather than a sharp spike, often reflects a steady, sustained buying trend building over multiple sessions rather than a one-off news-driven rally. For a company like Laurus Labs, this pattern typically points to continued investor confidence in the underlying business rather than a single catalyst.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Laurus Labs Share Price Today: Key Levels
  • Why the Laurus Labs share price Continues to Rally
  • What This Means for Investors
  • Conclusion
  • Frequently Asked Questions on Laurus labs share price
    • What is the Laurus Labs share price today?
    • What does Laurus Labs manufacture?
    • Why is the Laurus Labs share price hitting record highs?
    • Is it a good time to buy after the Laurus Labs share price hits an all-time high?
    • Where can I track the Laurus Labs share price live?
    • What sector does Laurus Labs belong to?

Laurus Labs Share Price Today: Key Levels

Metric Detail
Latest Price Rs 1,823.90
Change +0.42% intraday
All-Time High Touched Today Rs 1,826.00
Sector Pharmaceuticals and active pharmaceutical ingredients (APIs)

Why the Laurus Labs share price Continues to Rally

Check the Univest Screener for pharma sector stocks

Laurus Labs manufactures active pharmaceutical ingredients and formulations, with a significant presence in antiretroviral drugs and a growing contract development and manufacturing organisation (CDMO) business. Stocks in the API and CDMO space have seen sustained investor interest as global pharmaceutical companies look to diversify their supply chains away from China, a trend that has benefited several Indian API manufacturers.

An all-time high in the Laurus Labs share price reflects the market’s ongoing re-rating of the stock, though investors should be mindful that stocks trading at record levels can also see sharper corrections if growth expectations are not met in subsequent quarters.

What This Means for Investors

Download the Univest iOS App or Univest Android App to track the Laurus Labs share price and pharma sector movers in real time.

A new all-time high in the Laurus Labs share price is a technical milestone that draws attention from momentum-focused investors, but should be weighed against the stock’s valuation and the company’s growth outlook. Investors are encouraged to review quarterly results and management commentary alongside price action before making investment decisions.

Conclusion

The Laurus Labs share price touched a fresh all-time high of Rs 1,826.00 in today’s session, extending its recent uptrend on continued investor interest in the API and CDMO space. Investors should track further price action and consult a SEBI-registered financial advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Laurus labs share price

What is the Laurus Labs share price today?

Ans. The Laurus Labs share price touched an all-time high of Rs 1,826.00 in today’s session before settling at Rs 1,823.90, up 0.42%.

What does Laurus Labs manufacture?

Ans. Laurus Labs manufactures active pharmaceutical ingredients (APIs) and formulations, with a significant presence in antiretroviral drugs and a growing CDMO business.

Why is the Laurus Labs share price hitting record highs?

Ans. The stock’s sustained uptrend reflects continued investor interest in the API and CDMO space, supported by global pharmaceutical companies diversifying their supply chains.

Is it a good time to buy after the Laurus Labs share price hits an all-time high?

Ans. Stocks at record highs should be evaluated on valuation and growth outlook rather than price momentum alone. Consult a SEBI-registered financial advisor before investing.

Where can I track the Laurus Labs share price live?

Ans. The Laurus Labs share price can be tracked live on the Univest platform alongside SEBI-registered research.

What sector does Laurus Labs belong to?

Ans. Laurus Labs operates in the pharmaceuticals sector, specifically active pharmaceutical ingredients (APIs), formulations and contract development and manufacturing (CDMO).



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply